HK's Jacobson Pharma rises on strong yearly profit forecast

Jacobson Pharma

03/05/2019 03:47

** Shares of Jacobson Pharma Corporation Ltd  2633.HK  climb
as much as 6 pct to HK$1.59, their highest since April 15, after
the generic drugs maker forecast a strong growth in its yearly
earnings
    ** The Hong Kong-based company expects its profit for fiscal
year ended in March to rise over 20 pct from a year ago amid
growth of generic drug business and cost control measures
 urn:newsml:reuters.com:*:nFWN22E0PF
     ** The yearly results are expected to be published before
end-June
    ** As of last close, the stock has fallen 13.3 pct so far
this year
    ** Jacobson Pharma has underperformed the Hang Seng Commerce
& Industry Index sector  .HSNC  by 6.6 percentage points in the
past one month
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
falls 1 pct, and the benchmark index  .HSI  slides 0.7 pct


 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)